NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) 1986 NO. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) 1986 NO. 38 - TABLE OF PROVISIONS 1. Commencement 2. Principal Regulations 3. Schedule 1 4. Schedule 2 5. Schedule 3 6. Schedule 5 SCHEDULE 1 SCHEDULE 2 SCHEDULE 3 SCHEDULE 4 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 1 Commencement 1. These Regulations shall come into operation on 1 April 1986. 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 2 Principal Regulations 2. In these Regulations, "Principal Regulations" means the National Health (Pharmaceutical Benefits) Regulations. 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 3 Schedule 1 3. Schedule 1 to the Principal Regulations is amended as set out in Schedule 1. 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 4 Schedule 2 4. Schedule 2 to the Principal Regulations is amended as set out in Schedule 2. 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 5 Schedule 3 5. Schedule 3 to the Principal Regulations is amended as set out in Schedule 3. 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - REG 6 Schedule 5 6. Schedule 5 to the Principal Regulations is amended as set out in Schedule 4. 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 1 SCHEDULE 1 Regulation 3 AMENDMENTS OF SCHEDULE 1 TO THE PRINCIPAL REGULATIONS 1. Omit item 276. 2. Omit item 710. 3. Omit item 718. 4. Omit item 719. 5. After item 923 insert the following item: "923A Physostigmine Salicylate". 6. Omit item 1199. ------------ 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 2 SCHEDULE 2 Regulation 4 AMENDMENTS OF SCHEDULE 2 TO THE PRINCIPAL REGULATIONS 1. Omit item 54. 2. Omit item 77, substitute the following item: "77 Dextran 40 Intravenous Infusion, B.P. Glucose, B.P., with Dextran 40 Intravenous Infusion, B.P. Sodium Chloride, B.P., with Dextran 40 Intravenous Infusion, B.P.". 3. After item 92 insert the following item: "92A Doxorubicin Hydrochloride-". 4. Omit item 125, substitute the following item: "125 Glucose, Anhydrous, B.P. Sodium Chloride, B.P., Potassium Chloride, B.P., Citric Acid, B.P., Sodium Citrate, B.P., and Anhydrous Glucose, B.P. Sodium Lactate Compound Intravenous Infusion, B.P., with Anhydrous Glucose, B.P.". 5. Omit item 202. ------------ 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 3 SCHEDULE 3 Regulation 5 AMENDMENTS OF SCHEDULE 3 TO THE PRINCIPAL REGULATIONS 1. After item 25 insert the following item: "25A Auranofin". 2. Omit item 83. 3. After item 87 insert the following item: "87A Doxorubicin Hydrochloride". 4. After item 113 insert the following item: "113A Human Menopausal Gonadotrophin". 5. After item 130 insert the following item: "130A Isotretinoin". 6. Omit item 246. ------------ 1986 No. 38 NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS (AMENDMENT) - SCHEDULE 4 SCHEDULE 4 Regulation 6 AMENDMENTS OF SCHEDULE 5 TO THE PRINCIPAL REGULATIONS 1. Omit item 22, substitute the following items: "22 (1) Bromocriptine Mesylate, Capsules, 5 mg (base) (2) Bromocriptine Mesylate, Capsules, 10 mg (base) With the written authority of the Secretary- Acromegaly, prior to surgery or radiotherapy or where surgery or radiotherapy is inappropriate Parkinson's disease where treatment with levodopa is unsatisfactory Pathological hyperprolactinaemia where appropriate surgery or radiotherapy is not indicated or has already been used with incomplete resolution 22A Bromocriptine Mesylate, Tablets, 2.5 mg (base) Urgent suppression of physiological lactation With the written authority of the Secretary- Acromegaly, prior to surgery or radiotherapy or where surgery or radiotherapy is inappropriate Parkinson's disease where treatment with levodopa is unsatisfactory Pathological hyperprolactinaemia where appropriate surgery or radiotherapy is not indicated or has already been used with incomplete resolution". 2. Omit item 35. 3. Omit item 40, substitute the following item: "40 (1) Chloramphenicol Capsules, B.P. Bacterial meningitis (2) Chloramphenicol Palmitate Mixture, B.P. Intracranial bacterial infections Intraocular infections Rickettsioses (3) Chloramphenicol Sodium Succinate, B.P. Typhoid The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient". 4. Omit item 44, substitute the following item: "44 Cholestyramine Bile salt malabsorption associated with ileal resection or proven ileal disease Hypercholesterolaemia Pruritis associated with partial biliary obstruction not responding to other therapy Severe diarrhoea associated with pelvic irradiation". 5. After item 47 insert the following item: "47A Clomiphene Tablets, B.P. With the written authority of the Secretary- Anovulatory infertility". 6. Omit item 50, substitute the following item: "50 Colestipol Hydrochloride Hypercholesterolaemia". 7. Omit item 52. 8. After item 66 insert the following item: "67 Doxorubicin Hydrochloride Acute leukaemia Breast cancer Endometrial carcinoma Ewing's sarcoma Gastric cancer Hepatoma Intravesicular use in bladder cancer Lymphoma Multiple myeloma Neuroblastoma Osteosarcoma Ovarian cancer Soft tissue sarcoma Thyroid cancer Wilms' tumour". 9. After item 92 insert the following item: "92A Isotretinoin With the written authority of the Secretary- Severe cystic acne not responsive to other therapy". 10. Omit item 95. 11. After item 101 insert the following item: "101A Mefenamic Acid Capsules, B.P. Dysmenorrhoea Menorrhagia". 12. Omit item 164, substitute the following item: "164 Tamoxifen Citrate Tablets, B.P. Recurrent or metastatic breast cancer". 13. Omit item 173. - NOTES 1986 No. 38*1* NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS*2* (AMENDMENT) *1* Notified in the Commonwealth of Australia Gazette on 27 March 1986. *2* Statutory Rules 1960 No. 17 as amended by 1960 Nos. 90 and 102; 1961 Nos. 59 and 137; 1962 Nos. 34, 101 and 114; 1963 Nos. 34, 69 and 107; 1964 Nos. 12, 57 and 135; 1965 Nos. 51, 151 and 152; 1966 Nos. 80 and 144; 1967 Nos. 67, 116 and 158; 1968 Nos. 44, 76, 88 and 146; 1969 Nos. 44, 107 and 185; 1970 Nos. 39, 94, 119 and 186; 1971 Nos. 44, 101, 136 and 154; 1972 Nos. 32, 121 and 205; 1973 Nos. 15, 57, 139 and 229; 1974 Nos. 37, 126 and 222; 1975 Nos. 50, 148 and 209; 1976 Nos. 84, 150, 195 and 255; 1977 Nos. 39, 125 and 221; 1978 Nos. 47, 142, 153 and 245; 1979 Nos. 51, 55, 144 and 250; 1980 Nos. 69, 213 and 338; 1981 Nos. 52, 212, 218 and 345; 1982 Nos. 69, 76, 179, 334 and 372; 1983 Nos. 28, 102, 116 and 292; 1984 Nos. 50, 148, 169 and 342; 1985 Nos. 32, 184 and 320.